Affordable Access

Publisher Website

TRPA1 mediates bladder hyperalgesia in a mouse model of cystitis

Authors
Journal
Pain
0304-3959
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Volume
155
Issue
7
Identifiers
DOI: 10.1016/j.pain.2014.03.023
Keywords
  • Bladder
  • Calcium Imaging
  • Cystitis
  • Hyperlagesia
  • Trpa1
  • Trpv1
  • Visceromotor Reflex
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Urinary bladder pain is a primary symptom associated with interstitial cystitis/painful bladder syndrome. We used systemic injections of cyclophosphamide (CYP), an alkylating antineoplastic agent, to induce cystitis and examine the roles of 2 channels previously demonstrated to be required for inflammatory visceral hyperalgesia: transient receptor potential vanilloid-1 (TRPV1) and ankyrin-1 (TRPA1). Injection of CYP (100mg/kg, i.p.) every other day for 5days was accompanied by bladder edema and urothelial ulceration, but without significant plasma extravasation or infiltration of neutrophils. Toluidine blue staining showed a significant increase in the number of degranulated bladder mast cells after CYP treatment. Despite this mild pathology, CYP-treated mice exhibited bladder hyperalgesia 1 day after the final injection that persisted 7days later. Although many previous studies of visceral hyperalgesia have reported changes in dorsal root ganglion neuron TRPV1 expression and/or function, we found no change in bladder afferent TRPV1 expression or sensitivity on the basis of the percentage of bladder afferents responsive to capsaicin, including at submaximal concentrations. In contrast, the percentage of bladder afferents expressing functional TRPA1 protein (ie, those responsive to mustard oil) increased ∼2.5-fold 1day after CYP treatment, and remained significantly elevated 7days later. Moreover, bladder hyperalgesia was reversed by acute treatment with the TRPA1 antagonist HC-030031 (300mg/kg, i.p.). Our results indicate that CYP-induced bladder hyperalgesia can be induced without robust inflammation or changes in primary afferent TRPV1. However, significant changes were observed in TRPA1 expression, and blockade of TRPA1 alleviated CYP-induced bladder hyperalgesia.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Antagonism of the transient receptor potential ank...

on Chemico-Biological Interaction... Apr 25, 2013

TRPA1.

on Handbook of experimental pharm... 2007

TRPA1.

on Handbook of experimental pharm... 2014
More articles like this..